Skip to content

Effect of wearable transcutaneous acupoint electrical stimulation wristband on postoperative nausea and vomiting in high-risk patients undergoing gynaecological laparoscopic surgery

Effect of wearable transcutaneous acupoint electrical stimulation wristband on postoperative nausea and vomiting in high-risk patients undergoing gynaecological laparoscopic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099712
Enrollment
Unknown
Registered
2025-03-27
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative nausea and vomiting

Interventions

Control group:Wearing model wristbands
Wristband group:Wearable transcutaneous P6 acupoint electrical stimulation wristband

Sponsors

The First Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-65 years; 2. Apfel score >=3 (1 point each for females, history of PONV or motion sickness, non-smoking, and postoperative opioid use); 3. American Society of Anesthesiologists (ASA) rating I or II; 4. Body mass index (BMI) 18-28kg/m^2; 5. The duration of the operation < 2.5h.

Exclusion criteria

Exclusion criteria: 1. Use of opioids and drugs known to have antiemetic effects during pregnancy or lactation, within 24 hours before surgery; 2. The watch is worn with a local infection or trauma 3. History of upper extremity nerve injury; 4. History of spinal cord surgery; 5. Severe diabetes mellitus and hypertension; 6. Coronary artery disease; 7. Severe liver and kidney dysfunction; 8. Vertebrobasilar artery stenosis or insufficient blood supply; 9. Previous cerebrovascular events; 10. Mental disorders and inability to communicate; 11.Participation in other clinical trials within 3 months.

Design outcomes

Primary

MeasureTime frame
Overall incidence of PONV within 24h postoperatively;

Secondary

MeasureTime frame
PONV severity within 24h postoperatively;Pain intensity at various timepoints;Rescue analgesic use within 24h postoperatively;Local and systemic complications;Time of the first exhaust;Patient satisfaction with antiemetic treatment;PONV incidence in specific periods;PONV severity in specific periods;The use of antiemetic rescue within 24h postoperatively;

Countries

China

Contacts

Public ContactWang Liangrong

The First Affiliated Hospital of Wenzhou Medical University

arerong@163.com+86 13587884540

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026